Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sheel BiotechNSE:SHEEL -1.69%21 3-Year ROIIC % is 11.56 as of Mar. 2026, which is 40% below its 10-year median of 19.13. GuruFocus rates NSE:SHEEL with a GF Score™ of 21/100. The stock has 2 warning signs investors should review. Among 1,827 Consumer Packaged Goods companies, Sheel Biotech ranks better than 63.88% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Sheel Biotech's 3-Year ROIIC % for the quarter that ended in Mar. 2026 was 11.56%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Sheel Biotech's 3-Year ROIIC % or its related term are showing as below:
NSE:SHEEL's 3-Year ROIIC % is ranked better than 63.88% of 1827
companies
in the Consumer Packaged Goods industry
Industry Median: 2.62
vs NSE:SHEEL: 11.56
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Sheel Biotech 3-Year ROIIC % Related Terms
Sheel Biotech 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Sheel Biotech's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sheel Biotech 3-Year ROIIC % Chart
Sheel Biotech Annual Data
Trend
Mar22
Mar23
Mar24
Mar25
Mar26
3-Year ROIIC %
0.00
0.00
0.00
26.70
11.56
Sheel Biotech Semi-Annual Data
Mar22
Mar23
Mar24
Mar25
Mar26
3-Year ROIIC %
0.00
0.00
0.00
26.70
11.56
NSE:SHEEL vs ADM, BG, TSN: 3-Year ROIIC % Comparison
For the Farm Products subindustry, Sheel Biotech's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sheel Biotech 3-Year ROIIC % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Sheel Biotech's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Sheel Biotech's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Sheel Biotech (NSE:SHEEL) has a 3-Year ROIIC % of 11.56 as of Mar. 2026. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Sheel Biotech and its competitors. This is 40% below median its historical median of 19.13. Over the past decade, Sheel Biotech's 3-Year ROIIC % has ranged from 11.56 to 26.70. According to the industry distribution chart, Sheel Biotech ranks #660 out of 1827 companies in the Consumer Packaged Goods industry, placing it in the top 36.1%.
Is Sheel Biotech's 3-Year ROIIC % too high?
Sheel Biotech's current 3-Year ROIIC % of 11.56 is 40% below median its 10-year median of 19.13. Over the past 10 years, this metric has ranged from a low of 11.56 to a high of 26.70. The Consumer Packaged Goods industry median 3-Year ROIIC % is 2.62. Sheel Biotech's value of 11.56 is 341.2% above this industry median. Based on the distribution chart, Sheel Biotech ranks #660 out of 1827 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Sheel Biotech has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Sheel Biotech's 3-Year ROIIC % compare to ADM and BG?
According to the Consumer Packaged Goods industry distribution chart, Sheel Biotech ranks #660 out of 1827 companies for 3-Year ROIIC %. This puts Sheel Biotech in the upper half of its industry. The industry median 3-Year ROIIC % is 2.62. Sheel Biotech's value of 11.56 is 341.2% above this benchmark. Historically, Sheel Biotech's own 3-Year ROIIC % has ranged from 11.56 to 26.70 over the past decade. While the company's 10-year median is 19.13 vs. the industry median of 2.62, Sheel Biotech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Consumer Packaged Goods company?
The median 3-Year ROIIC % among Consumer Packaged Goods companies is 2.62, based on 1,827 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sheel Biotech's current 3-Year ROIIC % of 11.56 is 341.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Sheel Biotech and its competitors. For the Consumer Packaged Goods industry, the median 3-Year ROIIC % is 2.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sheel Biotech's current 3-Year ROIIC % is 11.56, which is 40% below median its own 10-year median of 19.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sheel Biotech stock overvalued right now?
Sheel Biotech (NSE:SHEEL) has a current 3-Year ROIIC % of 11.56. The current 3-Year ROIIC % is 11.56, which is 40% below median its 10-year median of 19.13 and 341.2% above the Consumer Packaged Goods industry median of 2.62. Sheel Biotech's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Sheel Biotech (NSE:SHEEL), the current 3-Year ROIIC % is 11.56 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sheel Biotech Ltd is engaged in the business of growing, developing, processing, and supplying a wide range of plants for field crops, fruits, vegetables, and ornamental plants through tissue culture and organic farming. It manufactures and maintain greenhouses, offer services to farmers and provide training through Farmer Producer Organizations (FPOs). The company also has a Research and Development lab with a capacity of production of 10 million* planting materials which is duly recognized by the Department of Biotechnology (DBT), Government of India.
21GF Score
Get the complete analysis for NSE:SHEEL
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SHEEL has been successfully added to your 
